[1] 倪兆慧,金海姣,中国腹膜透析发展70年[J].中国血液净化,2019, 18(10):661-663. [2] Campbell D, Mudge DW, Craig JC, et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis pa-tients [J]. Cochrane Database Syst Rev, 2017,4(4):CD004679. [3] Zhou Q, Bajo MA, del Peso G,etal. Preventing peritone-al membrane fibrosis in peritoneal dialysis patients [J]. Kid-ney Int,2016,90(3):515-524. [4] Li PK, Szeto CC, Piraino B,et al. ISPD peritonitis re-com-mendations: 2016 update on prevention and treatment [J]. Perit Dial Int, 2016,36(5):481-508. [5] Inoshita H, Ohsawa I, Onda K,et al. An analysis of func-tional activity via the three complement pathways during hemodialysis sessions: a new insight into the association between the lectin pathway and C5 activation [J]. Clin Kid-ney J,2012,5(5):401-404. [6] Kourtzelis I, Markiewski MM, Doumas M,et al. Comple-ment anaphylatoxin C5a contributes to hemodialysis-associ-ated thrombosis [J]. Blood, 2010,116(4):631-639. [7] Meijvis SCA, Herpers BL, Endeman H,et al.Mannose-binding lectin (MBL2) and ficolin- 2 (FCN2) polymor-phisms in patients on peritoneal dialysis with staphylococ-cal peritonitis [J]. Nephrol Dial Transplant, 2011,26(3): 1042-1045. [8] Andy Tang SO, Carolisna YI, Sakura D,et al. Demo-graphic characteristics and outcomes of continuous ambula-tory peritoneal dialysis related peritonitis in Miri General Hospital, Malaysia [J]. Med J Malaysia,2019,74(4):270-274. [9] Piraino B. Innovations in treatment delivery, risk of perito-nitis, and patient retention on peritoneal dialysis [J]. Semin Dial,2017,30(2):158-163. [10] 马东红,吕玉敏,刘云,等.腹膜透析相关性腹膜炎临床特点与危险 因素分析[J].中国血液化,2018,17(2):73-77. [11] Kerschbaum J, Vychytil A, Lhotta K, et al. Treatment with oral active vitamin D is associated with decreased risk of peritonitis and improved survival in patients on peritone-al dialysis[J]. PLoS One, 2013,8(7):e67836. [12] Carozzi S, Nasini MG, Schelotto C, et al. Effects of Ca++ and1,25(OH)2D3 on peritoneal immune-cell cyto-kine release and fibroblast proliferation in CAPD patients [J]. Adv Perit Dial, 1989,5(1):111-120. [13] 张宁,张蓓茹,何平,等.早发性腹膜透析相关性腹膜炎的危险因素 及预后研究[J].中国全科医学,2019,22(14):1696-1701. [14] 中国医师协会肾内科医师分会肾性贫血诊断和治疗共识专家组. 肾性贫血诊断与治疗中国专家共识[J].中华肾脏病杂志,2014,30 (9):712-715. [15] 穆霖,傅淑霞.慢性肾脏病患者甲状旁腺激素水平对肾性贫血的影 响[J].中华肾脏病杂志,2011,27(4):266-270. [16] 马晓莉,孙雪峰,丁巍,等.继发性甲状旁腺功能亢进症对肾性贫血 的影响[J].军事医学,2011,35(3):211-213. [17] Niu HX, Tang X, Zhou WD,etal. Frequent peritoneal di-alysis- related peritonitis: clinical characteristics, risk fac-tors and treatments [J]. Nan Fang Yi Ke Da Xue Xue Bao,2010,30(4):855-858. [18] 王磊,左力.炎症对慢性肾脏病贫血的影响[J].中国血液净化, 2017,16(8):505-508. [19] De Muster R, Grootendors DC, Indemans F,et al. Asso-ciation between serum alumin and mort ality in dialysis pa-tients in partly explainded by inflammation, and not by malnutrition[J]. J Ren Nutr, 2009,19(2):127-135.